TCM
AVNS icon

Tributary Capital Management’s Avanos Medical AVNS Stock Holding History

Tributary Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-810,720
Closed -$9.92M – 168
2025
Q2 		$9.92M Buy
810,720
+73,518
+10% +$925K 0.88% 57
2025
Q1 		$10.6M Sell
737,202
-155,806
-17% -$2.43M 0.92% 56
2024
Q4 		$14.2M Buy
893,008
+246,379
+38% +$4.88M 1.1% 49
2024
Q3 		$15.5M Sell
646,629
-96,427
-13% -$2.2M 1.21% 45
2024
Q2 		$14.8M Buy
743,056
+601
+0.1% +$11.7K 1.23% 44
2024
Q1 		$14.8M Buy
742,455
+51,865
+8% +$1M 1.21% 43
2023
Q4 		$15.5M Sell
690,590
-16,532
-2% -$341K 1.3% 41
2023
Q3 		$14.3M Buy
707,122
+9,274
+1% +$210K 1.35% 39
2023
Q2 		$17.8M Buy
697,848
+118,098
+20% +$3.11M 1.6% 22
2023
Q1 		$17.2M Buy
579,750
+27,474
+5% +$798K 1.6% 24
2022
Q4 		$14.9M Sell
552,276
-27,494
-5% -$672K 1.49% 29
2022
Q3 		$12.6M Sell
579,770
-6,347
-1% -$166K 1.32% 37
2022
Q2 		$16M Buy
586,117
+48,172
+9% +$1.38M 1.59% 21
2022
Q1 		$18M Buy
537,945
+26,487
+5% +$853K 1.42% 23
2021
Q4 		$17.7M Buy
511,458
+188,512
+58% +$6.09M 1.34% 28
2021
Q3 		$10.1M Buy
+322,946
New +$11M 0.78% 60

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tributary Capital Management's AVNS Position: Q3 2025 in Review

Tributary Capital Management sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 810,720 shares — an estimated $9.92M sold.

Tributary Capital Management first reported a position in AVNS in Q3 2021 and held it in 16 quarters. The position peaked at $18M in Q1 2022. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Tributary Capital Management reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Tributary Capital Management sold 810,720 Avanos Medical shares in Q3 2025, an estimated $9.92M.
  • Tributary Capital Management first reported a position in Avanos Medical in Q3 2021 and held it in 16 quarters.
  • Tributary Capital Management's Avanos Medical position peaked at $18M in Q1 2022.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Tributary Capital Management's 13F filing for Q3 2025, filed 23 Oct 2025.